InsiderClue
← All stocks

CRISPR Therapeutics AG

CRSP Net selling
CIK 0001674416 #1275 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$16.87M
$5.73M on a plan · $3.89M straight out of an exercise
Sold at will
$7.25M
16 of 26 sales
Net
−$16.87M
−$7.25M against sales at will

By person

8 insiders · 26 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Kulkarni Samarth
Chief Executive Officer
—
$10.76M (9)
−$10.76M
255,501
0.2642%
$14.21M
−17.1%
Prasad Raju
Chief Financial Officer
—
$5.10M (10) scheduled
−$5.10M
14,815
0.0153%
$824.01K
+128.8%
KASINGER JAMES R.
General Counsel and Secretary
—
$645.90K (5)
−$645.90K
94,308
0.0975%
$5.25M
+51.6%
Patel Naimish
Chief Medical Officer
—
$362.60K (2)
−$362.60K
19,357
0.0200%
$1.08M
+3,170%
George Simeon
Director
—
—
—
1,730,179
1.79%
$96.23M
+133.7%
Treco Douglas A
Director
—
—
—
22,000
0.0228%
$1.22M
+1,000%
Bruno Julianne
Chief Operating Officer
—
—
—
10,544
0.0109%
$586.46K
+56.3%
Greene John
Director
—
—
—
7,000
0.0072%
$389.34K
—

Individual transactions

6
Insider
Date
Role
Action
Shares
Price
Amount
Kulkarni Samarth
22 Jan 2026
Chief Executive Officer
Sold on a plan
60,000
$60.23
$3.61M
Kulkarni Samarth
20 Jan 2026
Chief Executive Officer
Sold on a plan
8,567
$52.10
$446.34K
Kulkarni Samarth
20 Jan 2026
Chief Executive Officer
Sold on a plan
21,433
$51.61
$1.11M
Prasad Raju
22 Dec 2025
Chief Financial Officer
Sold on a plan
1,000
$56.89
$56.89K
Prasad Raju
22 Dec 2025
Chief Financial Officer
Sold on a plan
5,472
$56.33
$308.26K
Prasad Raju
22 Dec 2025
Chief Financial Officer
Sold on a plan
3,528
$55.10
$194.40K
Show all 26 transactions →

What was left out

Form 4 filings counted 41
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 4
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 343,132
History held since 20 Oct 2016